Entrust just posted its Q2 2027 scorecard and the headline is clear. Profit held up while the share price told a more cautious story. The stock closed at ¥1,157 on 30 October, only slightly higher over the past week, even as basic earnings per share printed at ¥23.13 on revenue of ¥3,561.01m.
The market reaction looks muted compared with the firm’s longer run of earnings growth and the current P/E of 14.1x. Sentiment appears more cautious. The figures indicate a business that continues to generate profit, while the valuation suggests investors may be positioning for a potential slowdown.
Like the earnings resilience at Entrust but uneasy about paying 14.1x P/E when sentiment looks wary and the share price is flat? Compare this setup with a curated screener of profitable stocks on steadier footing in our list of solid balance sheet and fundamentals stocks (21 results)
Ask Charlie what makes Entrust look undervalued despite its P/E.
Entrust looks like a steady social infrastructure play when you line the story up against the Q2 print. Revenue moved from ¥2,977.69m to ¥3,561.01m while net income excluding extra items and basic EPS both edged higher by about 5.2%. Profit margin on a trailing 12 month view sits at 13.7%, only slightly below 13.9%. That combination of higher sales and still solid profitability fits a business tied to ongoing needs, such as rent and medical related guarantees, rather than a high volatility credit cycle trade.
There is still ammunition for a cautious view. Net income and EPS grew more slowly than revenue, which lines up with the modest margin compression from 13.9% to 13.7%. That is not a severe squeeze, yet it hints at either pricing pressure or higher underlying costs in the guarantee and operations mix. The flat 30 day return, around down 0.9%, and the small 7 day gain of 3.5% also point to investors treating these results as solid but not a clear catalyst that rewrites the risk story.
With Entrust trading on 14.1x P/E while margins edge lower, the real question is whether liquidity, leverage and cash generation actually support this valuation. Check the full financial health analysis of Entrust stock before drawing conclusions.Entrust just reported earnings and showed how solid results and cautious pricing can coexist. The real opportunity is hunting for stocks that could be undervalued before the market corrects them.
Three companies from the same screener. Open every one of the 15 undervalued companies on it →
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com